Picture of Arcoma AB logo

ARCOMA Arcoma AB Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapContrarian

Annual cashflow statement for Arcoma AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line3.51-8.793.134.6613.7
Depreciation
Non-Cash Items1.430.088-1.070.109-0.609
Other Non-Cash Items
Changes in Working Capital-1.40.65-8.836.3-2.14
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities6.85-1.93-0.17919.218.8
Capital Expenditures-11.7-4.19-4.17-2.55-6.78
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Cash from Investing Activities-11.7-4.19-4.17-2.55-6.78
Financing Cash Flow Items6.5-3.058.35-18.30
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities11.22.49.65-21.2-3.87
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash6.38-3.754.83-4.668.38